Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Journal of Psychoactive Drugs|March 27, 2025
Perceived Importance of Counseling Among Patients Receiving Methadone TreatmentDeclan T Barry, Mark Beitel, Marina Gaeta Gazzola, et al.Journal of General Internal Medicine|September 27, 2022
What's in a Name? Terminology Preferences Among Patients Receiving Methadone TreatmentMarina Gaeta Gazzola, Emma Maclean, Mark Beitel, et al.The International Journal on Drug Policy|August 27, 2025
Pre-implementation findings on the barriers and potential solutions to initiate same-day antiretroviral therapy among people who inject drugs in MalaysiaDavid Oliveros, Grazele Jenarun, N A Mohd Salleh, et al.Addiction (Abingdon, England)|February 18, 2018
An investigation of an open-access model for scaling up methadone maintenance treatmentLynn M Madden, Scott O Farnum, Kathryn F Eggert, et al.Annals of Internal Medicine|December 8, 2025
Integrating Methadone Services Into Primary Care in Ukraine: Two-Year Outcomes From a Randomized TrialEteri Machavariani, Denise Esserman, Kostyantyn Dumchev, et al.Journal of Psychoactive Drugs|July 3, 2023
Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance TreatmentUzoji Nwanaji-Enwerem, Mark Beitel, David E Oberleitner, et al.Addiction (Abingdon, England)|March 19, 2026
Latent classes of sleep deficiency and correlates among patients receiving methadone treatment: A longitudinal studyConnie Hsaio, Sangchoon Jeon, Kimberly A DiMeola, et al.BMC Health Services Research|March 29, 2025
Using nominal group technique to identify and prioritize barriers to decentralizing HIV care to primary health centers in Lima, PeruDavid Oliveros, Kelika A Konda, Lynn M Madden, et al.Addiction (Abingdon, England)|May 29, 2024
The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in UkraineRoman Ivasiy, Lynn M Madden, Anna Meteliuk, et al.Contemporary Clinical Trials|September 12, 2024
Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in UkraineEteri Machavariani, Kostyantyn Dumchev, Iryna Pykalo, et al.Pageof 8